Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ultivue is a life sciences company developing and commercializing innovative solutions for high-performance biological imaging in situ. Their proprietary InSituPlex® and UltiMapper® technologies enable advanced multiplex immunofluorescence, allowing researchers to visualize and quantify multiple biomarkers simultaneously within intact tissue samples. This technology is crucial for advancing immuno-oncology research, drug development, and personalized medicine by providing deeper insights into the tumor microenvironment and cellular interactions. Ultivue aims to accelerate breakthroughs in understanding complex diseases and developing targeted therapies.
The Cambridge headquarters serves as Ultivue's primary center for research and development, manufacturing of their proprietary reagents, commercial operations, and corporate administration.
Located within a vibrant biotech ecosystem, providing access to top talent, leading academic institutions, and numerous potential collaborators. The facility likely houses state-of-the-art laboratories for mIF assay development and reagent production.
The work culture at Ultivue's Cambridge HQ is likely dynamic, innovative, and highly collaborative, driven by a shared scientific mission to advance tissue biomarker discovery and improve patient outcomes, particularly in oncology.
Being in Cambridge allows Ultivue to be at the forefront of biotech innovation, facilitating partnerships with pharmaceutical companies and research institutions in close proximity.
Ultivue supports researchers and pharmaceutical companies globally, with a significant presence in North America, Europe, and key markets in the Asia-Pacific region. This global reach is achieved through its Cambridge headquarters, dedicated regional commercial and support teams, and a network of specialized distribution partners. They provide their InSituPlex® and UltiMapper® kits, as well as contract research services, worldwide to support immuno-oncology research, biomarker discovery, and clinical trial sample analysis.
763D Concord Avenue
Cambridge
MA
USA
Address: Specific office address not publicly listed; operations supported by regional teams.
To provide direct sales, technical support, and application services for Ultivue's multiplex immunofluorescence solutions to European clients.
Address: Specific office address not publicly listed; operations supported by regional teams and distribution partners.
To facilitate access to Ultivue's technology, provide localized support, and build strategic partnerships in key APAC markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ultivue' leadership includes:
Ultivue has been backed by several prominent investors over the years, including:
Ultivue has actively strengthened its leadership team over the past 1-2 years, with key appointments in R&D, Sales & Marketing, and Finance to drive its next phase of growth and innovation. Some transitions have occurred as the company scales its operations and commercial reach.
Discover the tools Ultivue uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ultivue likely utilizes common corporate email formats. Based on publicly available information and common industry practices, the most probable format is the first initial followed by the last name.
[first_initial][last]@ultivue.com
Format
jdoe@ultivue.com
Example
80%
Success rate
Business Wire • April 8, 2024
Ultivue announced its new AI-powered mIF workflow solution at the American Association for Cancer Research (AACR) Annual Meeting 2024. This solution aims to streamline image analysis and data interpretation for multiplex immunofluorescence assays....more
Business Wire • May 15, 2023
Ultivue announced the appointment of Florian Dählmann, Ph.D., as Vice President of R&D, and Chris Drohan as Vice President, Global Sales & Marketing, to bolster its innovation pipeline and commercial expansion....more
Business Wire • March 6, 2023
Ultivue highlighted its expanded offerings, including new UltiMapper kits and services, at the United States and Canadian Academy of Pathology (USCAP) 2023 Annual Meeting, emphasizing their utility in advancing immuno-oncology and spatial biology research....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ultivue, are just a search away.